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Sensing of apoptotic cells through Axl causes lung
basal cell proliferation in inflammatory diseases
Naoya Fujino1,3*, Oliver J. Brand1,2*, David J. Morgan1,2*, Toshifumi Fujimori1, Aleksander M. Grabiec1,4, Christopher P. Jagger1,2,
Rose A. Maciewicz5,6, Mitsuhiro Yamada3, Koji Itakura3, Hisatoshi Sugiura3, Masakazu Ichinose3, and Tracy Hussell1,2
Epithelial cell proliferation, division, and differentiation are critical for barrier repair following inflammation, but the initial
trigger for this process is unknown. Here we define that sensing of apoptotic cells by the TAM receptor tyrosine kinase Axl is a
critical indicator for tracheal basal cell expansion, cell cycle reentry, and symmetrical cell division. Furthermore, once the
pool of tracheal basal cells has expanded, silencing of Axl is required for their differentiation. Genetic depletion of Axl triggers
asymmetrical cell division, leading to epithelial differentiation and ciliated cell regeneration. This discovery has implications for
conditions associated with epithelial barrier dysfunction, basal cell hyperplasia, and continued turnover of dying cells in
patients with chronic inflammatory pulmonary diseases.
Introduction
Basal cells reside at variable frequency throughout the airway
epithelium, immediately above the basement membrane, and are
responsible for normal epithelial barrier maintenance through
transdifferentiation and replenishment (Evans et al., 2001; Hajj
et al., 2007; Rock et al., 2009, 2010). The epithelial barrier con-
tains a variety of cell types including ciliated, secretory, and
undifferentiated cells (Knight and Holgate, 2003). Replenishment
of the appropriate cell type requires intimate contact with adja-
cent cells and sensingmechanisms to replace the correct damaged
compartment (Evans et al., 2001). Basal cells express keratin 5
(Krt5) and -17, integrins ITG-A6, -B1, and -B4, and transcription
factors tumor protein p63 (TP63) and basonuclin and are en-
riched for genes associated with vascular endothelial growth
factor, transforming growth factor-β, NF-κB, mitogen-activated
protein kinases, and Notch signaling (Hackett et al., 2011; Ryan
et al., 2014). This mosaic of potential interactions, together with
factors secreted by a damaged epithelial compartment, most
likely determines basal cell function and differentiation (Paul
et al., 2014; Tadokoro et al., 2014, 2016; Gao et al., 2015; Pardo-
Saganta et al., 2015; Balasooriya et al., 2016). Basal cell hyperplasia
and a loss of apical ciliated and nonmucous secretory cells are
common features of chronic obstructive pulmonary disease
(COPD) and suggest that communication to repair the epithelial
barrier has gone wrong (Puchelle et al., 2006; Crystal, 2014;
Shaykhiev and Crystal, 2014b). In vitro experiments using air–
liquid interface cultures suggest that in COPD, excessive secretion
of ligands for epidermal growth factor receptors by differentiated
airway epithelial cells leads to an abnormal transition of basal
cells to squamous epithelial cells and reduced ciliated and
SCGB1A1-producing nonmucous secretory cells (Shaykhiev et al.,
2013). Therefore, sensing of an abnormal environment can itself
lead to progressive disorder of the barrier epithelium.
Basal cells in the adult trachea are dormant in health but
reenter the cell cycle to repopulate damaged cells in response to
insults such as sulfur dioxide (Borthwick et al., 2001; Rawlins
et al., 2009; Tata et al., 2013), naphthalene (Hsu et al., 2014),
polidocanol (Paul et al., 2014), and H1N1/PR8 influenza A virus
(Buchweitz et al., 2007; Tata et al., 2013). However, the trigger
for cell cycle reentry and the decision for proliferation versus
differentiation are unclear.We reasoned that another significant
component of a damaged environment is the presence of apo-
ptotic cells and that these might be the initiating factor for basal
cell proliferation and their hyperplasia in lung disease. Recog-
nition of apoptotic cells by phagocytes restricts inflammatory
responses to prevent inflammation and autoimmunity to self
(Hochreiter-Hufford and Ravichandran, 2013; Poon et al., 2014;
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Arandjelovic and Ravichandran, 2015). In addition to phag-
ocytes, recognition of apoptotic cells is important for main-
taining tissue homeostasis by nonimmune cells, including (i)
myoblast fusion inmurine skeletal muscles (Hochreiter-Hufford
et al., 2013), (ii) lipid metabolism of macrophages in mice (Fond
et al., 2015), and (iii) cellular proliferation in Hydra (Chera et al.,
2009), Drosophila (Fan and Bergmann, 2008), and mice (Li et al.,
2010). Among these novel roles of apoptotic cells in multiple
biological processes, the induction of cellular proliferation (so-
called apoptosis-induced compensatory proliferation) is of par-
ticular interest due to its relevance to clinical oncology and
regenerative medicine (Bergmann and Steller, 2010; Ryoo and
Bergmann, 2012). Mitogens, such as Hedgehog or Wnt, released
from apoptotic cells in a caspase-dependent manner are postu-
lated to stimulate proliferation of surrounding viable cells.
The TAM (Tyro3, Mer, and Axl) receptor tyrosine kinase family
recognizes apoptotic cells by binding the C-terminal sex
hormone–binding globulin-like domain of Protein S or Gas6, whose
N-terminal Gla domains bridge the TAM receptors to phosphati-
dylserine on the surface of apoptotic cells (Lemke and Rothlin,
2008; Lemke, 2013). The requirement for different TAM receptor
family members is beginning to be unraveled: Mer acts as a tol-
erogenic receptor under homeostatic conditions, whereas Axl is
critical for resolution of inflammation under pathological con-
ditions (Zagórska et al., 2014), including following influenza A virus
infection (Fujimori et al., 2015). In oncology, Axl is a potent driver
of proliferation, invasion, and metastasis of cancers through epi-
thelial-to-mesenchymal transition (Zhang et al., 2012; Asiedu et al.,
2014; Cichon´ et al., 2014). In addition, our recent study indicated
that Axl regulates differentiation of human lung tissue–derived
progenitor cells (Fujino et al., 2017). Axl may therefore recognize
cell death during tissue damage and convert this into multiple in-
tracellular signals for cellular proliferation and differentiation.
Beyond apoptotic cell recognition and efferocytosis, the
function of TAM receptors, in particular Axl, is not currently
known. Here we show that basal cells in tracheal epithelium
express Axl that is constitutively bound to the bridgingmolecule
Gas6. Furthermore, in the presence of apoptotic cells, usually
dormant basal cells reenter the cell cycle and undergo sym-
metrical cell division, producing more basal cells. In the absence
of Axl, basal cells undergo asymmetric cell division to other
epithelial cell components. This is the first time the presence and
absence of a single apoptotic cell recognition receptor has been
shown to define an alternate cellular outcome. With increased
apoptotic cell turnover in the lungs of patients with chronic
disease (Hodge et al., 2005), our results also explain the char-
acteristic basal cell hyperplasia and lack of effective barrier re-
pair in these patients. This pathway is targetable and currently
of interest in oncology, potentially providing a realistic strategy
for a therapeutic regimen targeting this facet of disease.
Results
The TAM receptor Axl is constitutively expressed on tracheal
basal cells in the steady state
We first examined whether TAM receptors were expressed on
cells in the murine tracheal epithelium. Basal cells, ciliated cells,
and two types of secretory cells (SSEA-1–positive or SSEA-1–
negative) were purified by FACS, and their identity was con-
firmed by analyzing lineage-specific markers by quantitative
RT-PCR (qRT-PCR; Fig. S1). Only basal cells expressed appre-
ciable levels of Axl compared with other tracheal epithelial cell
subsets (Fig. 1 A). Expression was confirmed by immunofluo-
rescence using an anti-mouse Axl antibody that clearly high-
lighted Axl expression on cells positive for the basal cell markers
Krt5 or TP63 (Fig. 1 B). The specificity of this antibody was
confirmed before using Axl−/− mice (Zagórska et al., 2014) and
repeated here (Fig. S1). Interestingly, the other TAM receptors,
Mer and Tyro3, were not expressed in any murine tracheal
epithelial cell subset, although we could confirmMer expression
on airway macrophages (Fujimori et al., 2015) and Tyro3 on
testicular sertoli cells (Lu et al., 1999; Fig. S1). Of total tracheal
Axl-expressing cells, 97.7 ± 1.0% or 97.3 ± 1.9% were positive for
Krt5 or TP63 (mean ± SEM of five individual mice), respectively,
supporting the mRNA data of selective expression of Axl in basal
cells. A recent study using single-cell qRT-PCR and lineage la-
beling identified two distinct subsets of Krt5-expressing basal
cells in the murine trachea: a basal stem cell population and a
basal luminal progenitor population (Watson et al., 2015). It
would appear that Axl is expressed by both, since 94.2 ± 1.4% of
total Krt5-expressing basal cells and 95.6 ± 1.4% of total TP63-
expressing basal cells express Axl (mean ± SEM of five indi-
vidual mice). Compared with the lung, there are very few
immune cells in the trachea (Fig. S2). We confirmed Axl ex-
pression on airway macrophages as reported previously
(Fujimori et al., 2015). However, we did not observe any staining
on the few immune cell subsets in the trachea, although we
cannot rule out expression by very low-frequency cells not de-
tected by flow cytometry.
Gas6 is a specific ligand for Axl and bridges its interaction
with externalized phosphatidylserine on apoptotic cells (Lew
et al., 2014; Zagórska et al., 2014). Similar to our previous ob-
servations of Axl expression on airway macrophages (Fujimori
et al., 2015), we observed constitutively bound GAS6 on Krt5-
expressing basal cells in WT C57BL/6 mice, but not in Axl
knockout mice (Fig. 1 C). Despite the loss of GAS6 from the
tracheal epithelium in Axl−/−, soluble levels similar to WT mice
were observed in the plasma (40,000 pg/ml) and airway lavage
fluid (4,000 pg/ml), suggesting that GAS6 production was un-
affected. Collectively, these data indicate that Axl, but not
MerTK or Tyro3, is preferentially expressed on tracheal basal
cells and, at homeostasis, constitutively bound to Gas6.
Before analysis of the role of basal cell Axl expression in
inflammation, we first examined whether its absence in Axl
knockout mice caused cell cycle reentry of this dormant cell
population in the steady state. Ki67 is present during all active
phases of the cell cycle (G1, S, G2, and mitosis) but is absent
from resting cells at G0 (Gerdes et al., 1984). Immunofluo-
rescence staining for Ki67+ basal cells (Krt5+) in both WT and
Axl−/− mice was infrequent (Fig. 1 D), nor was there any dif-
ference in total basal cell number (Fig. 1 E) or the number
(Fig. 1 F) and proportion (Fig. 1 G) of basal cells in cell cycle in
the steady state. Therefore, Axl alone does not cause basal cell
proliferation.
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Figure 1. Axl expression on basal cells in murine tracheal epithelium under homeostatic conditions. (A) qRT-PCR analysis of Axl mRNA expression in
epithelial cell subsets sorted from murine trachea. Each symbol represents data pooled from 10 tracheas, and lines indicate the mean value. (B) Im-
munostaining of murine tracheal epithelium indicating apicolateral expression of Axl protein on airway basal cells marked by Krt5 (left panel) or TP63 (right
panel) at steady state. (C) Immunostaining indicating constitutive binding of Gas6 to Axl expressed on Krt5+ airway basal cells at steady state inWT C57BL/6 or
Axl−/−mice. (D) Immunostaining of murine tracheal epithelium for Ki67+ (magenta)/Krt5+ (green) basal cells inWT C57BL/6 or Axl−/−mice. (E–G) The number of
Krt5+ basal cells per 100 µm trachea (E), the number of Krt5+Ki67+ basal cells per 100 µm trachea (F), and the percentage of Krt5+Ki67+ basal cells to total Krt5+
basal cells (G) between C57BL6 and Axl−/−mice at steady state. Data are expressed as mean ± SEM of five individual mice. Scale bars represent 20 µm (B and C)
and 50 µm (D).
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Axl promotes cell cycle reentry and DNA synthesis of basal
cells in influenza-infected mice
Axl is reported to be critical for apoptotic cell recognition during
inflammation (Zagórska et al., 2014; Fujimori et al., 2015;
Fourgeaud et al., 2016), so a lack of an effect on basal cells in Axl
knockout at homeostasis was unsurprising. We therefore next
used the H1N1/PR8 influenza A virus infection model as an in-
flammatory insult for the following reasons. First, the PR8 in-
fluenza strain causes a high level of virus replication and severe
pulmonary inflammation in C57BL/6 mice compared with other
influenza A virus strains including BJx109 andHKx31 (Tate et al.,
2011). Second, influenza A virus selectively infects ciliated epi-
thelial cells via α2,3-linked sialic acid, so any damage would be
next to basal cells (Ibricevic et al., 2006). Finally, influenza A
virus infection induces apoptosis and proliferation of epithelial
cells widely in murine tracheas (Buchweitz et al., 2007). We
confirmed that intranasal influenza virus infection caused the
loss of ciliated epithelial cells (acetylated tubulin–positive) by
day 3, with recovery of the epithelial barrier by day 14 (Fig. 2 A).
During influenza virus–induced injury, Axl-expressing basal
cells were in close contact with cleaved caspase 3–positive ap-
optotic epithelial cells (Fig. 2, B and C). Immunofluorescence
staining for apoptotic cells within basal cells (cCasp3 and Krt5+
cells) was never observed. Unlike homeostasis (Fig. 1 D), in the
context of inflammatory lung disease, basal cells entered the cell
cycle, an effect lost in Axl knockout mice (Fig. 2 D). Further-
more, the number of basal cells per 100 µm trachea (Fig. 2 E) and
the number and proportion of cycling Ki67+/Krt5+ cells (Fig. 2, F
and G) was reduced in Axl knockout mice. A role for Axl in cell
cycle reentry was further confirmed in an ex vivo culture, where
basal cells sorted from Axl−/− mice displayed less Ki67 compared
with those sorted from C57BL/6 mice (Fig. S3). In addition, basal
cells in the trachea of Axl−/− mice sequestered less 5-ethynyl-29-
deoxyuridine (EdU), a thymidine analogue taken up during DNA
synthesis, than WT mice (Fig. S3). Taken together, these data
show that in an inflammatory setting with apoptotic cells, Axl
promotes cell cycle reentry and proliferation of basal cells.
Apoptotic cells are associated with cell cycle reentry of
tracheal basal cells via Axl
Despite juxtaposed basal cells and apoptotic cells, inflammation-
induced basal cell proliferation could be due to a multitude of
other factors. To indicate a direct effect of apoptotic cells, we
therefore intranasally delivered murine apoptotic thymocytes
into C57BL/6 mice and quantified Ki67-expressing basal cells.
The number and percentage of Ki67+/Krt5+ basal cells to total
basal cells increased after apoptotic thymocyte administration
(Fig. 3, A and B). If apoptotic cells are inducing basal cell pro-
liferation via Axl, then their delivery to Axl knockout mice
should have a reduced effect. Total basal cell numbers remained
unaffected (not depicted). However, the number and proportion
of basal cells entering the cell cycle was significantly reduced in
Axl knockout mice (Fig. 3, C–E). These data indicate that apo-
ptotic cells trigger cell cycle reentry and that Axl kinase plays a
significant role. The reduction of basal cell proliferation in Axl
knockout mice also implies that instillation of a high volume of
thymocytes per se does not affect basal cells indirectly.
Although other Axl-expressing cells do not appear to be
present in the trachea at homeostasis, they may be recruited
during influenza infection. Therefore we performed influenza
virus infection in CCR2 knockout mice that are unable to release
monocytes from the bone marrow (Boring et al., 1997). Without
monocytes, their recruitment to the trachea, and differentiation
into macrophages that might express Axl, is inhibited. In this
system, basal cells still proliferated, often at greater levels than
WT controls, which likely reflects the increased disease severity
in this knockout mouse strain (Fig. 4).
An absence of Axl causes asymmetric basal cell division
Above, we showed that recognition of apoptotic cells via Axl
causes basal cells to proliferate to produce more basal cells
(symmetric division). However, murine basal cells also divide
asymmetrically to replenish the multiple epithelial cell subsets
in vivo (Paul et al., 2014). Asymmetric cell division, in which a
single cell divides into two distinct cell types, is a biologically
fundamental and evolutionally conserved process to generate a
diversity of descendant cell types (Jan and Jan, 1998). Although
intrinsic factors, such as oxidative stress pathways, regulate cell
division symmetry in vitro (Paul et al., 2014), the extrinsic fac-
tors that control cell division symmetry in response to injury
in vivo are undefined. We therefore asked whether Axl recog-
nition of apoptotic cells influenced cell division symmetry under
inflammatory conditions. To assess this, we measured the divi-
sion angle of paired mitotic basal cells relative to basement
membrane by immunofluorescence staining (Paul et al., 2014).
Localization of survivin allows visualization of paired mitotic
cells, since it is selectively expressed in the spindle midbody that
appears in anaphase and telophase during mitosis (Williams
et al., 2011). Fig. 5 A shows representative images of symmetric
or asymmetric division of pairedmitotic basal cells in the trachea
8 d after influenza infection. In symmetric division, basal cells
divide horizontally to the basement membrane and display
similar expression of the basal cell markers, TP63 and Krt5
(Fig. 5 A, upper panels). In contrast, in asymmetric division,
basal cells divide vertically to the basement membrane resulting,
in one TP63hi/K5hi basal cell on the basement membrane and
above it (the other side of the spindle midbody) a TP63−/K5low
cell that does not have the basal cell phenotype on the apical side
(Fig. 5 A, lower panels). We sought to quantify this by plotting
TP63 intensity ratio and cell division angle of each pair of
survivin-positive mitotic basal cells and verified a significant
correlation between these two parameters (Fig. 5 B). Generally,
the lower the expression of TP63, the greater the division angle
relative to the basementmembrane (asymmetric division). Axl−/−
mice displayed less TP63 intensity and had a greater division
angle (Fig. 5 B). 48% of paired mitotic basal cells in WT C57BL/6
mice showed symmetric division (within 20° relative to the
basement membrane), whereas only 26% of divisions were
symmetric in Axl−/− mice 8 d after influenza infection (Fig. 5 C).
To further confirm that Axl regulates cell division symmetry,
we used a three-dimensional (3D) organoid culture assay, which
enables visualization of cell fates at the single-cell level ex vivo
(Rock et al., 2011). As shown in Fig. S3, basal cells sorted from
tracheas of WT or Axl−/− mice were cultured on top of
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Figure 2. Reduced cell cycle reentry of airway basal cells in Axl−/− mice in response to influenza virus–induced epithelial injury in vivo. (A) Im-
munostaining of murine trachea epithelium for Krt5 (basal cell, green) and acetylated tubulin (a-tub; ciliated cell, magenta) after infection with H1N1/PR8
influenza A virus, confirming injury and repopulation of airway epithelium. (B) Immunofluorescent staining of cleaved caspase3 (cCasp3)–positive apoptotic
cells (magenta) and their close contact with Axl+ cells (green). (C)Magnified views of the area indicated by white rectangle in B. (D)Murine trachea epithelium
from C57BL/6 and Axl−/− mice after 8 d of influenza infection was stained for Ki67 (magenta) and Krt5 (green). (E–G) The number of Krt5+ basal cells per
100 µm trachea (E), the number of Krt5+Ki67+ basal cells per 100 µm trachea (F), and the percentage of Krt5+Ki67+ basal cells to total Krt5+ basal cells (G)
between C57BL6 and Axl−/− mice 8 d after influenza inoculation. Data are combined from two independent experiments and are shown as mean ± SEM. *, P <
0.05; **, P < 0.01 vs. C57BL/6; two-tailed unpaired t test. Nuclei (blue) were stained with DAPI (A–D). Scale bars represent 10 µm (A and B), 5 µm (C), and
50 µm (D).
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extracellular matrices containing an Axl-activating antibody to
fully activate the Axl signaling pathway. We observed 56
spheres from WT mice and 53 from Axl−/− mice at the two-cell
stage and measured the TP63 intensity ratio of these two di-
viding cells (Fig. 5 D). This confirmed a significant decrease in
basal cell–specific TP63 intensity ratio in spheres from Axl−/−
mice compared with WT mice (Fig. 5 E). This suggests that Axl
plays two roles: (i) in the presence of apoptotic cells, it promotes
basal cell expansion by symmetric cell division, and (ii) an ab-
sence of Axl allows basal cell differentiation into other cell types
by asymmetric cell division.
An absence of Axl promotes reepithelialization during
influenza infection
If our theory is correct that Axl kinase promotes symmetric
division of tracheal basal cells and inhibits their differentiation,
Figure 3. Axl has an important role in apoptotic cell–triggered cell cycle reentry of airway basal cells in vivo. (A) Immunostaining of murine tracheal
epithelium for Ki67+ (magenta)/Krt5+ (green) basal cells in WT C57BL/6 mice after intranasal delivery of apoptotic thymocytes. (B) The number of Krt5+Ki67+
basal cells per 100 µm trachea (upper) and the percentage of Krt5+Ki67+ basal cells to total Krt5+ basal cells (lower) following intranasal administration of
apoptotic thymocytes (0–6 d after administration). Data from one experiment with five mice per time point are expressed as mean ± SEM. *, P < 0.05; **, P <
0.01 vs. naive group (day 0); two-tailed unpaired t test. (C) Immunostaining of Ki67+ (magenta)/Krt5+ (green) airway basal cells in C57BL/6 and Axl−/− mice 1 d
after intranasal administration of apoptotic thymocytes. (D and E) The number of Krt5+Ki67+ basal cells per 100 µm trachea (D) and the percentage of
Krt5+Ki67+ basal cells to total Krt5+ basal cells (E) in Axl−/− mice compared with C57BL/6 mice 1 d after administration of apoptotic thymocytes. Data are
representative of two independent experiments and are expressed as mean ± SEM of five individual mice. *, P < 0.05 vs. C57BL/6; two-tailed unpaired t test.
Nuclei (blue) were stained with DAPI, and scale bars represent 20 µm (A and C).
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then Axl−/− mice should exhibit accelerated ciliated cell re-
population after injury. To test this, we measured the area of
cilia (acetylated tubulin–positive) in the trachea of mice infected
with H1N1/PR8 influenza A virus. Although the area of cilia was
equally reduced 3 d after infection in both WT and Axl−/− mice,
we observed a significant increase in the cilia area in Axl−/−mice
8 d after infection (Fig. 6, A and B).We further confirmed this by
demonstrating up-regulation of Foxj1 expression (a transcrip-
tion factor selectively expressed by airway ciliated epithelial
cells) in Axl−/− mice (a 1.8-fold increase in the ratio of Foxj1+
ciliated cells to K5+ basal cells/µm airway; Fig. 6, C and D). These
data suggest that Axl is required to induce proliferation of basal
cells and to suppress differentiation of basal cells into ciliated
cells for reepithelialization.
An absence of Axl has long-term consequences on the tracheal
epithelial barrier
We next examined how an absence of Axl affects the tracheal ep-
ithelial barrier at later time points after influenza infection. Before
infection, the tracheal ciliated epithelium was indistinguishable
between WT and Axl−/− mice. However, at later time points, par-
ticularly day 21, the epithelium appeared different in Axl−/− mice,
with reduced cilia (Fig. 7, A–C), decreased epithelial thickness
(Fig. 7 D), and a reduction in the number of nucleated cells (Figs. 7 E
and S4). This implies that although epithelial barrier repair is faster
in the absence of Axl, over the long term it is aberrant, and that
these alterations are apparent only following epithelial cell death.
An increase in apoptotic cells is associated with proliferation
of Axl+/TP63+ basal cells in the airway of patients with COPD
So far, using murinemodels, we have demonstrated that sensing
of apoptotic cells under inflammatory conditions initiates mu-
rine tracheal basal cell proliferation through Axl receptor tyro-
sine kinase. We further sought to confirm this idea in the human
setting and explore clinical relevance to human airway inflam-
matory diseases. COPD is a common, preventable, and treatable
disease characterized by persistent respiratory symptoms and
airflow limitation due to airway and/or alveolar abnormalities,
usually caused by significant exposure to noxious particles or
gases (Vogelmeier et al., 2017). Aberrant proliferation and
function of basal cells and an abnormal increase in apoptotic
epithelial cells participate in the airway inflammation and ob-
struction seen in the pathogenesis of COPD (Hodge et al., 2005;
Shaykhiev and Crystal, 2014b). Here we asked if human airway
basal cells expressed Axl as with murine tracheal basal cells and
evaluated how the presence of apoptotic cells was linked to Axl-
expressing basal cells in airways of patients with COPD.
A transcriptome analysis of central, large-airway epithelial
subsets previously revealed a sixfold increase in AXL mRNA
expression of airway basal cells compared with differentiated
luminal cells (Hackett et al., 2011). Here wewished to investigate
Axl expression in the small airways (i.e., <2 mm internal di-
ameter) in peripheral lung tissues, because small airways, but
not large airways, are major sites of obstruction in patients with
COPD (Hogg et al., 1968; Van Brabandt et al., 1983; Yanai et al.,
1992). We used a monoclonal antibody against a cytoplasmic
domain of Axl to prevent detection of the soluble form of Axl
that is shed by inflammatory stimuli (Zagórska et al., 2014). The
patient characteristics in our histological assessment are shown
in Table 1. Unlike with ∼97% Axl expression on murine tracheal
basal cells (Fig. 1 B), 24.4 ± 1.6% (mean ± SEM) of TP63+ basal
cells expressed Axl in small-airway epithelium of control never-
smokers (Fig. 8, A and B). The number and percentage of Axl+/
TP63+ basal cells were significantly increased in COPD ex-
smokers compared with those in control never-smokers and
control ex-smokers (Fig. 8, B and C). The number of Axl+/TP63+
basal cells correlated with functional airway obstruction
(i.e., disease severity; Fig. 8 D). Furthermore, Ki67-expressing
Axl+/TP63+ basal cells in the epithelium was observed only in
COPD (Fig. 8, E and F), suggesting that the increase in the
number of Axl+/TP63+ basal cells in COPD was at least partially
due to their proliferation. We next evaluated the presence of
apoptotic cells using immunohistochemistry for cleaved caspase
3. We found a significant increase in cleaved caspase 3–positive
Figure 4. Increased cell cycle reentry of air-
way basal cells in CCR2−/− airways following
resolution of influenza virus infection. Rep-
resentative immunostaining of murine tracheal
epithelium of C57BL/6 and CCR2−/− mice, for
Ki67 (green), Krt5 (red), and nuclei (blue) at 14 d
after H1N1/PR8 influenza A infection. Two rep-
resentative images are shown for each mouse
strain at 14 d after influenza virus infection. All
images were obtained using 20× objective lens
with scale bars, 50 µm.
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Figure 5. Decreased symmetric division of airway basal cells in Axl−/−mice in response to influenza virus–induced epithelial injury in vivo and in a 3D
organoid culture ex vivo. (A) Representative examples of immunodetection of symmetric (top panels) and asymmetric (bottom panels) divisions in tracheas of
C57BL/6 mice 8 d after H1N1/PR8 influenza virus infection; TP63 (red), Survivin (green), and Krt5 (K5; white). Yellow arrows indicate pairedmitotic cells. Yellow
dotted lines show basement membrane, and white faint lines on the left side panels indicate the direction of cell division. (B) Correlation of the TP63 intensity
ratio and the cell division angle of each paired mitotic basal cell (n = 21 Axl−/− and 27 C57BL/6; Spearman’s rank-order coefficient, rs, = −0.8669, P < 0.0001).
(C) Reduced symmetric division of basal cells in trachea in Axl−/− mice compared with C57BL/6, **, P = 0.0013; χ2 test. Data in B and C are combined from two
independent experiments with three individual mice per experiment. (D) Representative images of spheres at the two-cell stage consisting of a pair of P63hi
basal cells (white arrows, upper panels) or a TP63hi basal cell (white arrow) with a TP63low progenitor cell (yellow arrowhead; lower panels). TP63, green;
F-actin, magenta; DAPI, blue. Scale bars represent 5 µm. (E) Axl-deficient basal cells show reduced the ratio of TP63 intensity at the two-cell stage. n = the
number of spheres observed. Data are combined from two independent experiments and are expressed as box-and-whiskers plot (error bars indicate 10th to
90th percentile). Outliers are shown as dots. ****, P < 0.0001 vs. C57BL/6, Mann–Whitney U nonparametric test.
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apoptotic cells in airway epithelium of COPD ex-smokers com-
paredwith control never-smokers and control ex-smokers (Fig. 8,
G and H).We also found that the abundance of apoptotic cells was
significantly correlated with functional airway obstruction (Fig. 8
I). Finally, this increase in caspase 3–positive apoptotic cells was
significantly correlated with Axl+/TP63+ basal cells or Ki67+/Axl+/
TP63+ proliferating basal cells (Fig. 8, J and K).
Discussion
We demonstrate here that apoptotic cells are associated with cell
cycle reentry of quiescent basal cells via Axl in inflammatory
lung diseases of mice and humans. The outcome is symmetric
cell division that increases the pool of proliferating basal cells.
However, to drive basal cell differentiation to ciliated epithelial
cells requires an absence of Axl. This approach is beneficial, as
repair of an epithelial barrier, while there is ongoing stress
leading to its apoptosis, would expend fruitless energy; differ-
entiation may therefore progress once Axl signaling has ceased.
The outcome of Axl signaling in basal cells fits with the early
pathological changes observed in a number of chronic lung
diseases. For example, defects in apoptotic cell clearance
(Schmidt and Tuder, 2010), predominantly by airway macro-
phages (McCubbrey and Curtis, 2013; Grabiec and Hussell, 2016)
Figure 6. Ciliated cell regeneration is pro-
moted in Axl−/− mice at an early phase of in-
fluenza virus–induced epithelial injury in
vivo. (A) Immunostaining of cilia (acetylated
tubulin, magenta) and basal cells (Krt5, green) of
mouse tracheas at day 8 after H1N1/PR8 influ-
enza A virus infection. (B) Quantification of area
covered by cilia/µm of airways. (C) Immuno-
staining of ciliated cells (Foxj1, magenta) and
basal cells (Krt5, green) of mouse tracheas 8 d
after infection of C57BL/6 or Axl-deficient mice.
Yellow arrows indicate nuclear staining of Foxj1
in ciliated cells. (D) Quantification of the number
of Foxj1+ ciliated cells/µm of airways (left graph)
and the ratio of Foxj1+ cells to Krt5+ basal cells
(right graph). Data are representative of two
independent experiments and are expressed as
mean ± SEM of three individual mice (B and D).
*, P < 0.05 vs. C57BL/6; two-tailed unpaired
t test. Nuclei (blue) were stained with DAPI, and
scale bars represent 25 µm (A and C).
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are observed in cystic fibrosis (Vandivier et al., 2009), idiopathic
pulmonary fibrosis (Morimoto et al., 2012), and COPD (Imai
et al., 2005; Demedts et al., 2006; Makris et al., 2009). Fur-
thermore, one of the earliest events in the development of COPD
is basal cell hyperplasia (Auerbach et al., 1961) and a change in
their transcriptome as disease develops (Crystal, 2014; Ryan
et al., 2014; Shaykhiev and Crystal, 2014b). An increase of pro-
liferating cells with basal cell–like features (cytokeratin 5/14–
positive, EGFR+) is also reported within the epithelium of cystic
fibrosis patients compared with controls (Voynow et al., 2005).
Figure 7. Epithelial repair in Axl−/− mice is defective following the resolution of influenza viral infection. (A and B) Representative images of im-
munostaining frommurine trachea epithelium from C57BL/6 (WT) and Axl−/−mice for cilia (acetylated tubulin, green), basal cells (Krt5, red), and nuclei (blue) at
day 0, 14, and 21 after H1N1/PR8 influenza A virus infection. Scale bars represent 50 µm. (B) Increased magnification (64×) of tracheal epithelium in the same
region as shown in A of mice tracheas at day 21 after influenza virus infection. Scale bars represent 25 µm. (C) Quantification of area covered by cilia/µm of
airways. (D) Quantification of epithelial thickness (µm) in the airways. (E) Quantification of epithelial surface area (basal cells to cilia) covered by nuclei (µm2)
per 100 µm of airway. Data are representative of mean (± SD) from three donors per condition. Each donor is identified by a different color (solid black, white
with black border, and solid gray). C57BL/6 mice are indicated by circles, and Axl−/− mice are indicated by squares. Each symbol represents one field of view.
*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, Mann–Whitney U nonparametric test.
Table 1. Patient characteristics in the histological analysis
Characteristic Control never-smokers Control ex-smokers COPD ex-smokers
Subjects (n) 8 10 11
Men/women 0/8 8/2a 8/3a
Age (yr) 71.1 ± 6.6 69.0 ± 10.2 70.1 ± 7.7
Smoking (pack/yr) 0.0 ± 0.0 37.5 ± 27.2a 53.2 ± 33.1b
FVC (% of predicted) 106.1 ± 15.6 105.0 ± 11.7 106.0 ± 13.4
FEV1 (% of predicted) 108.4 ± 16.0 114.1 ± 20.2 75.5 ± 14.9a,c
FEV1/FVC (%) 78.3 ± 7.0 81.1 ± 8.0 55.7 ± 10.2a,c
GOLD (I/II/III/IV) 4/7/0/0
Data are presented as mean ± SD. FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; GOLD, Global Initiative for Chronic Obstructive Lung
Disease.
aP < 0.01.
bP < 0.001 vs. control never-smokers.
cP < 0.001 vs. control ex-smokers.
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Figure 8. Proliferation of Axl-expressing basal cells is correlated with the abundance of apoptotic cells in small airways of patients with COPD. (A)
Immunostaining of human small airway epithelium for P63 (a basal cell marker, green) and Axl (magenta) in control never-smokers (CNS), control ex-smokers
(CES), and ex-smokers with COPD. Yellow arrows or white arrowheads indicate Axl+/TP63+ cells or Axl−/TP63+ cells, respectively. Dotted lines show basement
membranes. (B and C) Quantification of the number of Axl-expressing TP63+ basal cells/µm airway (B) and the percentage of Axl-expressing TP63+ basal cells
to total TP63+ basal cells (C) in CNS, CES, and COPD. (D) Correlation between Axl+/TP63+ cell number/µm airway and airflow limitation detected as forced
expiratory volume in 1 s (FEV1, %pred). (E) Immunostaining for Ki67 (red), TP63 (green), and Axl (magenta) in small airways of COPD lung tissues. Yellow arrows
indicate Ki67+/Axl+/TP63+ cells. Dotted lines show basement membranes. (F) The increase in the Ki67-expressing Axl+/TP63+ basal cells in COPD compared
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Our results would suggest that apoptotic cell excess and basal
cell proliferation might be linked via the expression of Axl.
A role for Axl in barrier repair is supported further by our
previous study showing that inhibition of Axl in vitro, using a
small molecule inhibitor or by siRNA in human lung-derived
multipotent cells, promotes epithelial cell traits including an
up-regulation of surfactant proteins. Conversely, the presence of
Axl controls a number of transcription factors associated with
epithelial-to-mesenchymal transition such as SNAI2, HOXA5,
TBX2, or TBX3 (Fujino et al., 2017). This raises the intriguing
possibility that Axl acts as a switch to repair epithelial barriers at
various levels of the respiratory tract. The current article drives
the extension of this concept into a whole-animal model, where
we identify traits relevant to several significant inflammatory
diseases. However, in the in vivo model, although we can infer a
direct effect of apoptotic cells on Axl-bearing basal cells, we
cannot entirely rule out an indirect effect on another epithelial
cell population.
In addition to basal cell hyperplasia and the presence of ex-
cess apoptotic cells, inflammatory lung diseases display a dis-
ordered airway epithelial barrier with shorter or absent cilia,
loss of cell junctions, excess mucus, and squamous metaplasia
(Auerbach et al., 1961; Kennedy et al., 1984; Lumsden et al., 1984;
Peters et al., 1993; Dye and Adler, 1994; Leopold et al., 2009;
Shaykhiev et al., 2011; Shaykhiev and Crystal, 2014a). Only 44%
of basal cells from smokers differentiate to a mucociliated epi-
thelium at air–liquid interface, compared with 88% from healthy
nonsmokers (Staudt et al., 2014). In addition to the continued
influence of noxious substances, the disordered epithelium may
arise because Axl on basal cells promotes their proliferation and
not their differentiation. Additionally, we show here that al-
though ciliated airway epithelial cells are restored faster in Axl
knockout mice compared with WT mice in response to injury,
the resultant barrier is thinner, with shortened cilia. An ab-
normal but complete epithelial barrier may therefore be com-
mon across multiple respiratory diseases.
An important question is why this situation arises, and we
believe the answer lies in how the system is alerted to the
presence of damage. In the lung, antigen alone rarely leads to
inflammation unless it is accompanied by structural damage.
Various cell types sense tissue damage by recognizing “mis-
placed” proteins such as damage-associated molecular patterns
including heat shock proteins, ATP, nucleosomes, mitochondrial
proteins, and alarmins (Seong and Matzinger, 2004; Bertheloot
and Latz, 2017). Such damage-associated molecular patterns are
kept to a minimum by the antiinflammatory process of apo-
ptosis. However, it would also be important for a system to sense
that excessive apoptotic cell turnover was occurring. We pro-
pose that apoptotic cells perform a function similar to an alarmin
that promotes basal cell activity to replace damaged epithelium
once apoptosis has ceased. The fact that basal cell hyperplasia
is not observed in health suggests that homeostatic apoptotic
cell turnover is not a sufficient signal in this process. Basal
cell proliferation may therefore depend on the extent of Axl
ligation and/or require additional microenvironmental cues
(Arandjelovic and Ravichandran, 2015). In addition to exter-
nalized phosphatidylserine, apoptotic cells also express on their
cell surface ICAM-3, oxidized low-density lipoprotein, calreti-
culin, annexin 1, thrombospondin, and C1q. However, these do
not compensate for a lack of Axl in driving basal cell prolifera-
tion, which highlights a surprising specificity of Axl’s effect.
That Axl is constitutively expressed on basal cells raises the
question of how Axl activity in this context is regulated. Basal
cells are usually shielded from the airway lumen by other epi-
thelial cells, and interstitial lung contents by the basement
membrane. In acute and chronic inflammatory diseases, both of
these shields are damaged in patches. Therefore, basal cell rec-
ognition of apoptotic cells by Axl is likely to occur only in
patches. This is supported by the small localized areas of basal
cell Ki67 staining that we observe by immunofluorescence
during influenza infection. That instilled apoptotic cells also
induced basal cell proliferation is interesting, as this process is
unlikely to denude epithelial cells. Phosphatidylserine-coated
exosomes released from cells that are small enough to transit
into the epithelial barrier may be present in this scenario
(Arraud et al., 2015). Another conundrum is that we might ex-
pect progressive depletion of basal cells in Axl knockout mice,
since it is required for basal cell cycle reentry during inflam-
mation. There are currently two explanations for why basal cells
are not depleted in Axl knockout mice. First, homeostatic
turnover of basal cells is likely to be Axl independent due to the
paucity of apoptotic cells, and second, basal cells in nondamaged
areas of epithelium may compensate through symmetric cell
division.
Phosphatidylserine is expressed in the virion coat of a
number of viruses and may facilitate virus entry through
phosphatidylserine-recognizing receptors. The outcome of this
route of infection is critical for determining whether the virus
then replicates or not. The human T cell immunoglobulin and
mucin domain proteins have been extensively studied in this
regard (Mercer and Helenius, 2008; Soares et al., 2008), but Axl
is also involved due to the binding of its bridging ligand, Gas6, to
phosphatidylserine. Alhough H1N1 influenza virus has not been
studied in this respect, H7N1 virus entry via this route leads to a
nonproductive infection (Jemielity et al., 2013). This, along with
the observation of major changes in the barrier epithelium long
after the virus has been cleared, suggests that viral entry into
basal cells is not a predominant cause of our results.
with CNS and CES. (G) Immunohistochemistry of cleaved caspase 3 (cCasp3, brown, arrows) in bronchiolar epithelium of human lung tissues from CNS, CES,
and COPD. Nuclei (purple) were visualized by hematoxylin. (H) Quantification of cCasp3-positive area/µm of airways. (I) Correlation between cCasp3-positive
area/µm of airways and FEV1, %pred. (J and K) cCasp3 positivity is correlatedwith the number of Axl+/P63+ cell number (J) and Ki67+/Axl+/TP63+ cell number in
human small airway (K). Nuclei (blue) were stained with DAPI (A and E). Scale bars represent 25 µm (A and E) and 50 µm (G). Data are expressed as median ±
interquartile range; Kruskal–Wallis test followed by Dunn’s multiple comparison test, *, P < 0.05; **, P < 0.01; ***, P < 0.001 (B, C, and H). rs, Spearman’s rank-
order coefficient (D, F, and I–K).
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Axl therefore contributes to significant clinical features as-
sociated with inflammatory lung disease, including basal cell
hyperplasia and disrupted epithelial basement membrane. This
suggests that Axl inhibition may be beneficial in a variety of
inflammatory lung disease settings. In this regard, therapeutics
are already in clinical trials, as members of the TAM receptor
family are aberrantly or ectopically expressed in many hema-
tologic and nonhematologic malignancies, where they con-
tribute to increased cell survival and proliferation, thereby
increasing resistance to chemotherapeutics and targeted agents
(Graham et al., 2014; Akalu et al., 2017). The tyrosine kinase
inhibitors, ligand traps, and monoclonal antibodies already de-
veloped could therefore be repurposed for chronic inflammatory
diseases such as COPD, which itself is associated with eventual
development of lung cancer.
Materials and methods
Mice
The generation of Axl−/− mice has been described previously (Lu
et al., 1999). All Axl−/− mice used in this study were backcrossed
to C57BL/6J background for ≥10 generations. C57BL/6J litter-
mates were bred in-house and used as controls and Ccr2tm1Ifc
(Boring et al., 1997). All experiments were approved under a
project license granted by the Home Office UK and by the Uni-
versity of Manchester Animal Welfare and Ethical Review Body
and were performed in accordance with the UK Animals (Sci-
entific Procedures) Act of 1986. Mice were bred and maintained
in specific pathogen–free conditions at Bio Safety Level 2 with a
12-h light/dark cycle, dry food pellets, and water ad libitum.
8–10-wk-old female mice were used for all in vivo experiments.
12–14-wk-old male and female mice were used for ex vivo cul-
ture assays.
Immunofluorescence staining and image analysis on
mouse tissues
For dissection of tissues, mice were euthanized by intraperito-
neal administration of 3 mg pentobarbitone and exsanguination
via the femoral artery. Tracheas, lungs, and testes were har-
vested, embedded in optimal cutting temperature medium, and
frozen in 2-methylbutane with dry ice. The tissues were sec-
tioned in a Cryostat at 10-µm thickness, and tracheas were cut
longitudinally. Sections were air-dried for 10 min and stored at
−80°C. For immunofluorescence staining, sections were fixed
with 4% paraformaldehyde for 30min, blocked with 10% donkey
serum/0.3% Triton X-100 in PBS for 30 min, and incubated at
4°C overnight with the following primary antibodies: rabbit
anti-Krt5 (#905501, 1 µg/ml; BioLegend); chicken anti-Krt5
(#905901, 1 µg/ml; BioLegend); rabbit anti-P63 (ab124762
[EPR5701], 3.3 µg/ml; Abcam); mouse anti-P63 (ab735 [4A4],
1/100; Abcam); goat anti-Axl (AF854, 4 µg/ml; R&D Systems);
goat anti-Mertk (BAF591, 4 µg/ml; R&D Systems); goat anti-
Tyro3 (AF759, 4 µg/ml; R&D Systems); goat anti-Gas6
(BAF986, 4 µg/ml; R&D Systems); rat anti-Ki67 (#13-5698
[SolA15], 2.5 µg/ml; eBioscience); rabbit anti–acetylated tubulin
(#5335 [D20G3], 1/800; Cell Signaling Technology); mouse anti-
Foxj1 (#14-9965 [2A5], 1 µg/ml; eBioscience); rabbit anti-cleaved
caspase 3 (#9664 [5A1E], 1/800; Cell Signaling Technology); and
rabbit anti-survivin (#2808 [71G4B7], 1/400; Cell Signaling
Technology). Mouse on Mouse Basic Kit (#BMK-2202; Vector)
was used for mouse-derived primary antibodies per the manu-
facturer’s instructions. After three washes for 5 min with PBS
containing 0.02% Tween 20, the following fluorochrome-
conjugated secondary antibodies were used: tetramethylrhod-
amine (TRITC)-donkey anti-rabbit IgG (711-025-152; Jackson
ImmunoResearch), Alexa Fluor 647–donkey anti-goat IgG (705-
605-147; Jackson ImmunoResearch), Alexa Fluor 488–donkey
anti-chicken IgY (703-545-155; Jackson ImmunoResearch), Alexa
Fluor 546–donkey anti-rabbit IgG (A10040; Life Technologies),
Alexa Fluor 546–donkey anti-mouse IgG (A10036; Life Tech-
nologies), Alexa Fluor 488–donkey anti-goat IgG (A11055; Life
Technologies) or fluorochrome-conjugated streptavidin (Alexa
Fluor 488–Streptavidin (S11223; Life Technologies), and Alexa
Fluor 647–Streptavidin (S21374; Life Technologies). Slides were
mounted and nuclei were stained using ProLong Diamond an-
tifade reagent with DAPI (Life Technologies).
Images were collected on an Olympus BX51 upright micro-
scope using a 20×/0.50 Plan Fln or 40×/0.75 Plan Fln objective
and captured using a Coolsnap ES camera (Photometrics)
through MetaVue Software (Molecular Devices). Specific band-
pass filter sets for DAPI, FITC, TRITC, and Cy5 were used to
prevent bleed-through from one channel to the next. Decon-
volved images were acquired on a Delta Vision (Applied Preci-
sion) restoration microscope using a 40×/1.30 Uplan Fln
objective and the Sedat filter set (Chroma 86000v2). The images
were collected using a Coolsnap HQ (Photometrics) camera with
a Z optical spacing of 0.2 µm. Raw images were then decon-
volved using Softworx software. Images were processed and
analyzed using ImageJ, and median-intensity projections of the
deconvolved images are shown.
For quantification, three independent sections from each
trachea were examined by referencing cartilage rings 2–9 ac-
cording to a previous publication (Tata et al., 2013). Cells that
expressed each specific marker were manually counted. Cell
division axis was determined in pairs of mitotic basal cells in
anaphase or telophase by survivin staining (Williams et al.,
2011). Cell division angle was defined as the angle between the
division axis to the basement membrane. The ratio of TP63
staining intensity of paired mitotic basal cells was quantified
using ImageJ as follows: (i) the outline of nuclei was delineated
by DAPI staining; (ii) the average intensity of TP63 staining
within the nucleus was measured and defined as TP63 inten-
sity; (iii) the ratio of TP63 intensity of paired mitotic cells was
calculated by dividing TP63 intensity of one daughter cell
(TP63Cell1) by TP63 intensity of another daughter cell (TP63Cell2),
where TP63Cell2 is always greater than TP63Cell1. The area of cilia,
which were visualized by positivity of acetylated tubulin in
tracheal epithelium, and the length of basementmembranewere
measured using ImageJ.
Isolation of murine tracheal cells
Murine tracheal cells were isolated using a Papain Dissociation
System per the manufacturer’s instructions (Worthington) and
previous reports (Tata et al., 2013; Zhao et al., 2014). Briefly,
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tracheas were cut into small pieces and incubated with papain
solution at 37°C for 1.5 h and serially passed through 19-, 21-, and
23-gauge needles. The suspension of cells was subsequently
filtered via a 70-µm cell strainer. Ovomucoid inhibitor solution
contained in the Papain Dissociation System was used to inhibit
the enzymatic activity of the papain solution, and debris was
removed by discontinuous density gradient. RBCs were lysed
with RBC lysis buffer (Roche).
FACS of epithelial cells from murine tracheas
Epithelial cell subsets were sorted from murine tracheas as de-
scribed previously (Tata et al., 2013; Zhao et al., 2014). Briefly,
single-cell suspensions were stained with Live/Dead Fixable
Near-IR Dead Cell Stain Kit (Life Technologies) per the manu-
facturer’s instructions. Fc receptors were then blocked using
purified anti-mouse CD16/CD32 (14-061-85 [clone 93], 1:100;
eBioscience) at 4°C for 20 min. Cells were stained with the fol-
lowing cocktail of antibodies and lectin in sterilized PBS con-
taining 1% BSA at 4°C for 30 min: PE-anti-mouse CD326
(EpCAM) antibody (118205, 1:100; BioLegend); PE/Cy7-anti-
mouse CD24 antibody (560536, 1:200; BD PharMingen); bio-
tinylated Griffonia simplicifolia isolectin (GSI)-β4 (L2140, 1:100;
Sigma-Aldrich); Alexa Fluor 647–anti-mouse/human CD15 (SSEA-1)
antibody (125608, 1:50; BioLegend). The samples were then in-
cubated with Brilliant Blue 515–conjugated streptavidin (564453,
1:100; BD Biosciences) at 4°C for 30min to detect biotinylated GSI-
β4. Cells were sorted using BD Influx. FlowJo (version 10) was
used for FACS analysis.
RNA extraction, RT, and qPCR
Total RNA was extracted using RNeasy Micro Kit (Qiagen) and
assessed for quantity and quality by UV spectrophotometry (ND-
2000 spectrophotometer; Nano Drop Technologies). cDNA was
synthesized from the extracted RNA using High-Capacity RNA-
to-cDNA Kit (Life Technologies). qPCR was performed using the
predesigned TaqMan expression assays and TaqMan Fast Uni-
versal PCRMasterMix (Life Technologies) on a QuantStudio 12K
Flex PCR system (Life Technologies) in duplicate. The TaqMan
expression assays used were Hprt, Mm01545399_m1; Trp63,
Mm00495793_m1; Scgb3a2,Mm00504412_m1; Foxj1,Mm01267279_m1;
and Axl, Mm00437221_m1. Hprt was used as the endogenous
control, and relative expression of mRNA was determined by the
ΔΔCt method.
Infection of influenza virus and EdU administration
Mice were anesthetized with isoflurane and intranasally in-
fected with 7.5 PFU of H1N1 influenza A virus, Puerto Rico/8/34
(PR8). EdU (0.5 mg/200 µl PBS per mouse; Life Technologies)
was intraperitoneally injected on days 3, 5, and 7 after influenza
infection. Mice were euthanized by intraperitoneal adminis-
tration of 3 mg pentobarbitone and exsanguination via the
femoral artery on day 8. Tracheas were harvested for subse-
quent experiments.
Intranasal administration of apoptotic thymocytes
For preparation of apoptotic or necrotic thymocytes, thymi were
harvested from 6–7-wk-old female C57BL/6 mice. Apoptotic cells
were obtained by incubation of thymocytes with 2.5 µM dexa-
methasone for 5 h. Mice were anesthetized with isoflurane and
intranasally administered with 50 µl of 0.8 mM CaCl2/PBS
containing 1.0 × 107 apoptotic cells.
Cell culture, whole-mount staining, and image analysis of a 3D
basal cell organoid assay
3D basal cell organoids were generated as previously described
(Rock et al., 2011) with some modification. Permanox 8-well
chamber slides (Corning) were coated with Matrigel (10
µl/well; Corning) on ice using an ice-cold tip and incubated
at 37°C for 10 min. EpCAM+GSI-β4+CD24− basal cells sorted from
murine trachea were seeded at 5,000 cells/well onto slides
precoated with 300 µl/well of mTEC/Plus medium (You et al.,
2002) containing 2%Matrigel and anti-Axl–activating antibodies
(AF854, 3 µg/ml at final concentration; R&D Systems). On day 1,
150 µl of culture supernatant per well was removed, and 150
µl/well mTEC/Plus medium containing the anti-Axl–activating
antibody was added. On day 2, slides were fixed with 4% para-
formaldehyde at room temperature for 30min. Basal cell spheres
were blocked and permeabilized with PBS containing 10% goat
serum (Sigma-Aldrich) and 0.3% Triton X-100 for 30 min. An
anti-P63 antibody (ab124762 [clone EPR5701]; Abcam) in block-
ing buffer was incubated overnight at 4°C. After rinsing slides
with PBS containing 0.02% Tween20, the slides were incubated
with Alexa Fluor 647–conjugated goat anti-rabbit antibody (Life
Technologies) in 2% goat serum/PBS for 60 min. After incuba-
tion with Alexa Fluor 555–conjugated phalloidin for 20 min,
slides were mounted, and nuclei were stained using ProLong
Diamond antifade reagent with DAPI (Life Technologies). De-
convolved image acquisition using Delta Vision and image
analysis for measuring TP63 intensity ratio were performed as
described above.
Ex vivo proliferation assay of murine airway basal cells
Sorted basal cells were cultured on a 96-well view plate
(#6005225; PerkinElmer) coated with rat tail collagen I
(5 µg/cm2; Corning) in DMEM (Sigma-Aldrich) containing
10 µg/ml insulin (Sigma-Aldrich), 5 µg/ml transferrin
(Sigma-Aldrich), 0.1 µg/ml cholera toxin (Sigma-Aldrich),
2% bovine pituitary extract (Lonza), 5% FBS (Life Technol-
ogies), 0.01 µM retinoic acid (Sigma-Aldrich), 50 nM full-
length mouse recombinant Gas6 (8310-GS; R&D Systems),
100 units/ml penicillin, 100 µg/ml streptomycin, and 0.25
µg/ml amphotericin B. 3 d after seeding, cells were fixed with 4%
paraformaldehyde for 30 min. After a blocking/permeabilization
step with 10% donkey serum/0.5% Triton X-100/PBS for 30 min,
cells were incubated with biotinylated rat anti-Ki67 antibody
(#13-5698 [SolA15], 2.5 µg/ml; eBioscience) overnight at 4°C. The
cells were then incubated with Alexa Fluor 555–conjugated
streptavidin for 15 min, and nuclei were stained with Hoechst
33342 (1 µg/ml at final concentration; Life Technologies) for
10 min. Images were acquired on a Leica DM IL LED inverted
microscope using a 20×/0.35 Dry N Plan L objective and captured
using a Leica DFC 3000G through Leica Application Suite Ad-
vanced Fluorescence software. Specific bandpass filter sets for
DAPI and TRITC were used to prevent bleed-through from one
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channel to the next. Images were processed and analyzed using
ImageJ. At least 300 nuclei weremanually counted in eachwell for
calculating the percentage of Ki67+ cells per total number of nuclei.
Human lung tissues and ethics
The study using human lung tissues was approved by the Ethics
Committee at the Tohoku University School of Medicine and the
Japanese Red Cross Ishinomaki Hospital. Lung tissues were ob-
tained from patients who underwent lung resection for lung
cancer at the Department of Thoracic Surgery at Tohoku Uni-
versity Hospital or the Department of Thoracic Surgery at Jap-
anese Red Cross Ishinomaki Hospital. Written informed consent
was received from all patients before surgery. Airflow limitation
was determined by spirometry and was defined as a post-
bronchodilator forced expiratory volume in 1 s/forced vital ca-
pacity <70%, and severity was classified in accordance with the
Global Initiative for Chronic Obstructive Lung Disease criteria
(Vogelmeier et al., 2017). Lung tissues distant from the cancer-
ous lesions were used, and we verified that no tumors were
included in sections analyzed by histopathology. We also con-
firmed that there was no overt inflammation and fibrosis in lung
sections of control never-smokers and control ex-smokers.
Immunofluorescence staining and immunohistochemistry for
human lung specimens
Lung tissues were fixed with 10% formalin, embedded in par-
affin, and sectioned at 3-µm thickness. Heat-induced antigen
retrieval by autoclave (for 5 min at 121°C) was performed using
Tris-EDTA buffer (10 mM Tris base, 1 mM EDTA, and 0.05%
Tween 20, pH 9.0). Triple immunofluorescence staining of Axl
in combination with Ki67 and TP63 was performed. Sections
were blocked and permeabilized for 30 min at room tempera-
ture with 0.3% Triton X-100/10% goat serum/PBS. The sections
were incubated overnight at 4°C with primary antibodies as
follows: anti-human Axl antibody (#8661, clone C89E7, rabbit
monoclonal, 1:100; Cell Signaling Technology); anti-human TP63
antibody (#735, clone 4A4, mouse IgG2a, 1:100; Abcam); and
anti-Ki67 antibody (#9449, clone 8D5, mouse IgG1, 1:200; Cell
Signaling Technology). Secondary antibodies were incubated
using Alexa Fluor 488–goat anti-mouse IgG2a antibody, Alexa
Fluor 555–goat anti-rabbit IgG(H+L) antibody, and Alexa Fluor
647–goat anti-mouse IgG1 antibody (1:200; Thermo Fisher Sci-
entific). After mounting of slides and staining of nuclei using
ProLong diamond antifade reagent with DAPI (Life Technolo-
gies), imageswere collected on a Nikon C2si confocal microscope
system using a 20×/0.75 Plan Apo or 60×/1.40 Plan Apo λ oil
objective through NIS-Elements C (Nikon) with Z spacing of
0.150 µm. Images were processed and analyzed using NIS-
Elements AR (Nikon), and maximum-intensity projections
are shown.
Cleaved caspase 3 was stained using Histofine SAB-PO(R) kit
(Nichirei) per the manufacturer’s instructions. Briefly after
heat-induced antigen retrieval using Tris-EDTA buffer as above,
sections were blocked with 10% goat serum buffer. Anti-cleaved
caspase 3 antibody (#9664, clone 5A1E, rabbit monoclo-
nal, 1:1,000; Cell Signaling Technology) was incubated over-
night at 4°C. After blocking endogenous peroxidase activity by
incubating for 30 min at room temperature using methanol and
3% hydrogen peroxide, sections were incubated with bio-
tinylated goat anti-rabbit antibody followed by streptavidin-
conjugated horseradish peroxidase. 3,39-Diaminobenzidine was
used for detection of the antigen–antibody complex. Nuclei were
visualized with hematoxylin. Images were acquired on an
Olympus BX53microscope using a 20×/0.50 UPlanFLN objective
and captured using a DP71/u-TV1X-2 camera through a DP con-
troller (Olympus). Images were processed and analyzed using
ImageJ. For quantification, three small airways in each section
were arbitrarily selected.
Statistical analysis
Prism version 5.0f (GraphPad Software) was used for all sta-
tistical calculations. For multiple dataset analysis, analysis of
variance with Bonferroni correction was applied. To compare
two datasets, unpaired t test or nonparametricMann–WhitneyU
test was applied as indicated in figure legends. Fisher’s exact test
was used to test association between two categorical variables.
To test correlation between two datasets, a Spearman rank-
order correlation coefficient (rs) and the P value were calcu-
lated. Data are presented as the mean ± SEM or SD as indicated
in figure legends. P values <0.05 were considered significant.
Online supplemental material
Fig. S1 shows the sorting strategy and validation of cellular
components in murine tracheal epithelium, the exclusive ex-
pression of Axl on basal cells, and the specificity of the anti-Axl
antibody. Fig. S2 shows that the mouse trachea contains very
few immune cells that express Axl. Fig. S3 shows details of how
basal cell proliferation or differentiation was assessed. Fig. S4
shows that epithelial thickness and the number of nuclei are
reduced in the absence of Axl.
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